Search Results - "Chelnokova, O. G"

Specific perception of the problem of tuberculosis by physicians from primary medical care by Chelnokova, O. G., Golovanova, M. N., Senin, I. G.

“…The objective : to study the perception of the problem of tuberculosis in physicians working in primary medical care and enhance motivation to implement…”
Get full text

Bronchial obstructive syndrome in primary infection with Mycobacterium tuberculosis in children by A. L. Salova, O. G. Chelnokova, L. I. Mozzhukhina, T. A. Kogut

“…Рurpose. The aim is to study the influence of primary Mycobacterium tuberculosis infection on the occurrence of bronchial obstruction syndrome in children…”
Get full text

Mycobacterium tuberculosis Infection and the development of laryngeal stenosis in children — is there a relationship? by A. L. Salova, O. G. Chelnokova, L. I. Mozzhukhina, T. A. Kogut

“…The aim is to study the relationship of Mycobacterium tuberculosis infection and the development of laryngeal stenosis (croup) in children. 250 children with…”
Get full text

Croup syndrome and primary infection with mycobacterium tuberculosis in children by Mozzhukhina, L. I., Chelnokova, O. G., Kogut, T. A., Salova, A. L.

“…Acute respiratory viral infections (ARVI) occupy an important place in infectious pathology of children’s age. One of the frequent and severe manifestations of…”
Get full text

SPECIAL SOFTWARE FOR DETECTION OF NIDI WITH UNFAVORABLE TB SITUATION AND HIGH RISK FOR CHILDREN TO BE INFECTED WITH TUBERCULOSIS IN THE REGION by Golovanova, M. N, Belikova, E. V., Chelnokova, O. G, Efremov, I. А., Romanova, Zh. V., Аverianova, N. G.

Get full text

Antituberculosis Properties of Methyldioxotetrahydropyrimidine Sulfonisonicotinoyl Hydrazide by B. S. Kibrik, O. G. Chelnokova, L. M. Terekhina, O. Yu. Sosnina

“…Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide (MSH) registered in Russia under the name of tubosan of the class…”
Get full text

Efficiency of Cytokine Therapy with Leukinferon for Multiple Organ Dysfunction, Pyoseptic Diseases, and Respiratory Distress Syndrome by Belyaev, D. L., Tsymbalov, O. V., Markelova, Ye. V., Kostyushko, A. V., Smirnov, G. A., Strusov, V. V., Babayants, A. A., Chelnokova, O. G., Kuznetsova, S. Yu, Frolova, I. S.

Get full text

SPECIAL SOFTWARE FOR DETECTION OF NIDI WITH UNFAVORABLE TB SITUATION AND HIGH RISK FOR CHILDREN TO BEINFECTED WITH TUBERCULOSIS IN THE REGION by M. N. Golovanova, E. V. Belikova, O. G. Chelnokova, I. A. Efremov, Zh. V. Romanova, N. G. Аverianova

Get full text

Bacteriological substantiation of the antituberculosis effect of immunotropic drug tubosan by Kibrik, B S, Pavlov, A V, Chelnokova, O G

“…The antituberculosis effect of tubosan registered in the Russian Federation as an immunostimulant drug has been studied on a series of 53 clinical strains of…”
Get more information

Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide by Kibrik, B S, Chelnokova, O G, Terekhina, L M, Sosnina, O Iu

“…Antituberculosis properties of methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydrazide (MSH) registered in Russia under the name of tubosan of the class…”
Get more information

Misdiagnosis of cheesy pneumonia in general hospitals and results of its treatment by O G Chelnokova, B S Kibrik

“…Aim. To specify diagnostic approaches to rapidly progressive destructive pulmonary tuberculosis (RPDPT) in general hospitals and effects of the time of the…”
Get full text

Errors in diagnosing pulmonary tuberculosis in general hospitals and results of treating the disease by Chelnokova, O G, Kibrik, B S

“…To specify diagnostic approaches to rapidly progressive destructive pulmonary tuberculosis (RPDPT) in general hospitals and effects of the time of the…”
Get more information

Diagnostic and treatment policy errors in caseous pneumonia by Kibrik, B S, Chelnokova, O G

“…Analysis of diagnostic and treatment policy in 314 patients with caseous pneumonia has identified a complex of factors that considerably affect the outcome of…”
Get more information

Extracorporeal antiaggregant pharmacotherapy in the treatment of acutely progressive forms of tuberculosis by Kibrik, B S, Chelnokova, O G

“…The investigation was undertaken to study whether extracorporeal pharmacotherapy with the antiaggregant pentoxiphylline (trental) might be used to correct…”
Get more information

Diagnostic features for the early variant of caseous pneumonia by Kibrik, B S, Chelnokova, O G

“…Examination of clinical, X-ray, and laboratory data of 312 patients with caseous pneumonia identified an early variant of this disease in 35%. The early…”
Get more information

Pathogenetic therapy for caseous pneumonia by Chelnokova, O G, Kibrik, B S

“…The efficiency of treatment was studied in 79 patients with caseous pneumonia, including 37 patients (a study group) in whom pathogenetic therapy was performed…”
Get more information

Problems of the epidemiology, diagnosis, and treatment of caseous pneumonia by Kibrik, B S, Chelnokova, O G

“…The pace on increases in new cases of caseous pneumonia in 1992-2001 is 50% ahead of that in the total number of new cases of pulmonary tuberculosis…”
Get more information

Some specific features of drug resistance of Mycobacteria tuberculosis in patients with acutely progressive destructive forms of pulmonary tuberculosis by Kibrik, B S, Chelnokova, O G

“…A clear correlation has been found between the drug resistance of Mycobacterium tuberculosis (MBT) and the degree of immunodeficiency in 127 patients with…”
Get more information

Use of isofon in combined treatment of patients with acutely progressive forms of tuberculosis by Chelnokova, O G, Kibrik, B S

“…Isofon given in a dose of 800 mg daily for 1.5-2 months contributed to clinical and X-ray involution of a process in 16 of the 19 patients with acutely…”
Get more information

Extracorporeal immunopharmacological therapy in the treatment of patients with acutely progressing froms of pulmonary tuberculosis by Chelnokova, O G, Kibrik, B S

“…Extracorporeal immune-pharmacological therapy, involving Diuciphonium, was added to the complex treatment of 46 patients primarily diagnosed as having acutely…”
Get more information